BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38677937)

  • 1. Corrigendum to "IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization" [Int. Immunopharmacol. 70 (2019) 69-79].
    Chen C; Ai QD; Chu SF; Zhang Z; Zhou X; Luo P; Liu YJ; Chen NH
    Int Immunopharmacol; 2024 May; 133():112154. PubMed ID: 38677937
    [No Abstract]   [Full Text] [Related]  

  • 2. IMM-H004 protects against oxygen-glucose deprivation/reperfusion injury to BV2 microglia partly by modulating CKLF1 involved in microglia polarization.
    Chen C; Ai Q; Chu S; Zhang Z; Zhou X; Luo P; Liu Y; Chen N
    Int Immunopharmacol; 2019 May; 70():69-79. PubMed ID: 30785093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats.
    Ai Q; Chen C; Chu S; Luo Y; Zhang Z; Zhang S; Yang P; Gao Y; Zhang X; Chen N
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMM-H004, a novel coumarin derivative compound, attenuates the production of inflammatory mediatory mediators in lipopolysaccharide-activated BV2 microglia.
    Song XY; Hu JF; Sun MN; Li ZP; Zhu ZX; Song LK; Yuan YH; Liu G; Chen NH
    Brain Res Bull; 2014 Jul; 106():30-8. PubMed ID: 24878446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
    Ai QD; Chen C; Chu S; Zhang Z; Luo Y; Guan F; Lin M; Liu D; Wang S; Chen N
    Transl Res; 2019 Oct; 212():36-53. PubMed ID: 31176667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMM-H004, a novel courmarin derivative, protects against oxygen-and glucose-deprivation/restoration-induced apoptosis in PC12 cells.
    Ji HJ; Wang DM; Hu JF; Sun MN; Li G; Li ZP; Wu DH; Liu G; Chen NH
    Eur J Pharmacol; 2014 Jan; 723():259-66. PubMed ID: 24291097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of oxygen-glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin.
    Wang J; Liu X; Wei W; Yang J; Li Q; Chu S; Liu P; Zhang J; He W
    Metab Brain Dis; 2023 Dec; 38(8):2627-2644. PubMed ID: 37837601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal chemokine-like-factor 1 (CKLF1) up-regulation promotes M1 polarization of microglia in rat brain after stroke.
    Zhou X; Zhang YN; Li FF; Zhang Z; Cui LY; He HY; Yan X; He WB; Sun HS; Feng ZP; Chu SF; Chen NH
    Acta Pharmacol Sin; 2022 May; 43(5):1217-1230. PubMed ID: 34385606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt1 activator SRT2104 protects against oxygen-glucose deprivation/reoxygenation-induced injury via regulating microglia polarization by modulating Sirt1/NF-κB pathway.
    Fu CY; Zhong CR; Yang YT; Zhang M; Li WA; Zhou Q; Zhang F
    Brain Res; 2021 Feb; 1753():147236. PubMed ID: 33412146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4.
    Chen C; Chu SF; Ai QD; Zhang Z; Guan FF; Wang SS; Dong YX; Zhu J; Jian WX; Chen NH
    Cell Mol Neurobiol; 2019 Jul; 39(5):651-669. PubMed ID: 30982091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats.
    Zhang Z; Liu D; Jiang J; Song X; Zou X; Chu S; Xie K; Dai J; Chen N; Sheng L; Li Y
    Front Pharmacol; 2019; 10():631. PubMed ID: 31249524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound IMM-H004, a novel coumarin derivative, protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia.
    Zuo W; Zhang W; Han N; Chen NH
    CNS Neurosci Ther; 2015 Mar; 21(3):280-8. PubMed ID: 25601434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.
    Chu SF; Zhang Z; Zhang W; Zhang MJ; Gao Y; Han N; Zuo W; Huang HY; Chen NH
    Mol Neurobiol; 2017 Jan; 54(1):524-540. PubMed ID: 26742528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Madecassoside protects BV2 microglial cells from oxygen-glucose deprivation/reperfusion-induced injury via inhibition of the toll-like receptor 4 signaling pathway.
    Luo Y; Wang C; Li WH; Liu J; He HH; Long JH; Yang J; Sui X; Wang S; You Z; Wang YA
    Brain Res; 2018 Jan; 1679():144-154. PubMed ID: 29198964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
    Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
    J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMM-H004, a novel coumarin derivative compound, protects against amyloid beta-induced neurotoxicity through a mitochondrial-dependent pathway.
    Song XY; Hu JF; Sun MN; Li ZP; Wu DH; Ji HJ; Yuan YH; Zhu ZX; Han N; Liu G; Chen NH
    Neuroscience; 2013 Jul; 242():28-38. PubMed ID: 23523945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMM-H004, A New Coumarin Derivative, Improved Focal Cerebral Ischemia via Blood-Brain Barrier Protection in Rats.
    Niu F; Song XY; Hu JF; Zuo W; Kong LL; Wang XF; Han N; Chen NH
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2065-2073. PubMed ID: 28669655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMM-H004, a Novel Coumarin Derivative Compound, Inhibits H
    Song XY; Hu JF; Wu DH; Ji HJ; Chen NH
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3396-3403. PubMed ID: 30243729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
    Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new coumarin derivative, IMM-H004, attenuates okadaic acid-induced spatial memory impairment in rats.
    Song XY; Wang YY; Chu SF; Hu JF; Yang PF; Zuo W; Song LK; Zhang S; Chen NH
    Acta Pharmacol Sin; 2016 Apr; 37(4):444-52. PubMed ID: 26838073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.